Missing/wrong data?
Log in to edit
Phase I dose-escalation study of EZN-2208 (PEG-SN38), a novel conjugate of poly(ethylene) glycol and SN38, administered weekly in patients with advanced cancer
scientific article published on 30 March 2013
Author/s
author: Saïk Urien, Larry J Schaaf, Tanios Bekaii-Saab
Work details
Publication date
March 30, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.